Indication: Used for the treatment of congenital or acquired immunodeficiency, improving the patient's cellular immune function and anti-infection ability. Treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. It has a certain therapeutic effect on certain viral, bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection. Used in combination with chemotherapy and radiotherapy to enhance the therapeutic effect and improve immunity. Used for anti-recurrence and anti-metastasis treatment after surgery, chemotherapy and radiotherapy of malignant tumors, and at the same time enhance immunity. Treat malignant pleural, abdominal and pericardial effusions. Used for biological immunotherapy of tumors that are not suitable for surgery, chemotherapy and radiotherapy.

Indication: For chronic hepatitis B patients over 18 years old. Because the thymus begins to atrophy after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.

Indication: 1 For chronic hepatitis B patients over 18 years old. Because the thymus begins to shrink after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.

Indication: For chronic hepatitis B patients over 18 years old. Because the thymus begins to atrophy after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.

Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.

Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.

Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.

Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.

Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.

Indication: Malignant tumors: The immune function of patients with malignant tumors such as lung cancer, liver cancer, ovarian cancer, kidney cancer, breast cancer, cervical cancer, osteosarcoma, digestive system tumors and blood cancers has been significantly restored, and auxiliary surgery, radiotherapy and chemotherapy programs have been well completed, and complications such as infection can be prevented and treated. It also has an important inhibitory effect on preventing the distant metastasis of tumor cells and the formation of new metastatic lesions; treatment of hepatitis B; major surgical operations and severe infections; autoimmune diseases, such as rheumatoid arthritis and lupus erythematosus; type 2 diabetes, menopausal syndrome; low immune function due to aging; skin diseases and sexually transmitted diseases (such as recurrent herpes and condyloma acuminatum); severe burns.